Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
2009
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
2015 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007
Misdiagnosis of stroke in tissue plasminogen activator–treated patients
2003
Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations
2011
Organizing regional networks to increase acute stroke intervention
2005
Intracerebral haemorrhage
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effect of statins in stroke prevention
2005
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
2005
Therapeutic Yield and Outcomes of a Community Teaching Hospital Code Stroke Protocol
2004
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Thrombolysis for Acute Stroke in Routine Clinical Practice
2002
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
Safety of Intravenous Thrombolytic Use in Four Emergency Departments Without Acute Stroke Teams
2010
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Stroke
2008 Standout
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
2000
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2012
Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals
2015
Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome
2011
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Statins and Intracerebral Hemorrhage
2011
Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES)
2001
Development of regional programs to speed treatment of stroke
2008
High-Dose Statin Therapy for Secondary Prevention of Stroke
2008
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Enhancing Community Delivery of Tissue Plasminogen Activator in Stroke Through Community–Academic Collaborative Clinical Knowledge Translation
2009
New and emerging data from clinical trials of statins
2004
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
2010 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
2000 Standout
Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
2001
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Predictors of good outcome after intravenous tPA for acute ischemic stroke
2001
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Hemorrhagic Transformation of Ischemic Brain Tissue
2001
Effectiveness of t-PA in acute ischemic stroke
2000
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study
2007
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice
2003
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
2002
Guidelines for the Primary Prevention of Stroke
2014 Standout
Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke
2006
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Improving Delivery of Acute Stroke Therapy
2002
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?
2000
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial
2004 Standout
Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated With Symptomatic Intracerebral Hemorrhage
2001
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
2004
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
2004
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies
2009
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
2003
An Updated Definition of Stroke for the 21st Century
2013 Standout
Quality improvement in acute stroke
2006
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke
2001
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
2009
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Thrombolysis for acute ischaemic stroke
2014
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Characteristics of Academic Medical Centers and Ischemic Stroke Outcomes
2001
Recommendations for the Establishment of Stroke Systems of Care
2005
Recommendations for the Establishment of Stroke Systems of Care
2005
Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
2002
Works of Diane Book being referenced
Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
2003
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey
1999